A novel non-agonist c-Met antibody drug conjugate with superior potency over a c-Met tyrosine kinase inhibitor in c-Met amplified and non-amplified cancers

Ryo FujitaResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Vincent BlotResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Eley WongResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Christine StewartResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Vincent LieuwResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Robyn RichardsonResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Ammar BanahResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Jose VillicanaResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Anjuli TimmerResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Julia CoronellaResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Roland NewmanResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USA

Marco GymnopoulosResearch Department, Tanabe Research Laboratories U.S.A., Inc, San Diego, CA, USACorrespondence[email protected]

Articles from other publishers (8)